Home›People›Todd Cozzens
Todd Cozzens

Todd Cozzens

Managing Partner, Transformation Capital and director at DexCare.

DirectorPublic company
Updated Nov 9, 2026·Latest SEC filing Sep 14, 2026·Suggest an edit

About Todd Cozzens

Todd Cozzens is a managing partner, transformation capital and director at DexCare.

Todd Cozzens reports to the SEC as a director of 2 public companies: Natera (NTRA) and Health Catalyst (HCAT).

Todd Cozzens first appears on SEC filings in 2015.

Experience

This experience comes from Todd Cozzens's profile and from SEC filings. For roles taken from filings, the years are when the filings name Todd Cozzens in the role, so the role may have started earlier or lasted longer.

Alaffia Health Current
Board Member
2025 – Present
DexCare, Inc. Current
Managing Partner, Transformation Capital and director
Board of Directors (2021 – Present)
2021 – Present · Seattle, WA
Patient navigation and scheduling software for health systems.
SWORD Health Current
Board Member
2021 – Present
Vital Current
Board of Directors
2021 – Present
Transformation Capital Current
Co-Founder & Managing Partner - Transformation Capital
2015 – Present
SmarterDx
Member Board of Directors
2024 – 2025
Natera, Inc.
Past Board of Directors
2011 – 2022 · Public company (NTRA)
PatientPing
Former Board Of Directors (Acquired by Appriss)
2016 – 2021
Health Catalyst, Inc.
Board of Directors (former) - NASDAQ: HCAT
2012 – 2020 · Public company (HCAT)
SCIO Health Analytics®
Former Board of Directors
2014 – 2018
ZirMed
Former Member of Board of Directors (acquired by Bain Capital in 2017)
2012 – 2017
MedExpress
Former Board of Directors (acquired by Optum in April, 2014)
2013 – 2015
Sequoia Capital
Partner, Healthcare
2012 – 2015
PerfectServe
Former Member of Board of Directors
2011 – 2015
Optum / UnitedHealth Group (NYSE: UNH)
CEO - Optum Accountable Care Solutions / Head of Strategy & M&A, Optum
2010 – 2012
Picis
CEO and Founder
2000 – 2010
Marquette Medical Systems
-
1990 – 1999

Key Colleagues at Startups

The people Todd Cozzens works with at each company, as listed on that company's latest Form D.

DexCare, Inc. · Form D, Sep 14, 2026
PM
Paul Minardi
Director
TC
BF
Branden Fini
Director
Caroline Xie
Caroline Xie
Director
MB
Matthew Blosl
Chief Executive Officer and director

Sources

  1. SECDexCare, Inc. Form D, filed Sep 14, 2026
  2. SECForms 3, 4 and 5 filed by Todd Cozzens (SEC filer 1382487)